Phase 2 Malabsorption Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 2

Assess the Safety of ELGN-2112 in Preterm Infants Born Under 26 Weeks GA and IUGR Infants Born 26-32 Weeks GA

Intestinal Malabsorption

Elgan Pharma Ltd.60 enrolled1 locationNCT05904626

Recruiting

Phase 2

Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants

Iron-Deficiency AnemiaIron-deficiencyPrematurity+1 more

University of Washington120 enrolled1 locationNCT05340465

Recruiting

Phase 2

Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)

Short Bowel SyndromeFunctional Gastrointestinal DisordersPost-Op Complication+2 more

Napo Therapeutics, S.p.A.18 enrolled8 locationsNCT06904872